Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. TNON
stocks logo

TNON

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2026Q1
1.38M
+79.03%
-0.370
-89.81%
1.40M
+92.98%
-0.340
-66.34%
Estimates Revision
The market is revising Upward the revenue expectations for Tenon Medical, Inc. (TNON) for FY2025, with the revenue forecasts being adjusted by 1.45% over the past three months. During the same period, the stock price has changed by -4.24%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.45%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+7.08%
In Past 3 Month
Stock Price
Go Down
down Image
-4.24%
In Past 3 Month
Wall Street analysts forecast TNON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNON is 2.75 USD with a low forecast of 2.50 USD and a high forecast of 3.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast TNON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNON is 2.75 USD with a low forecast of 2.50 USD and a high forecast of 3.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.130
sliders
Low
2.50
Averages
2.75
High
3.00
Current: 1.130
sliders
Low
2.50
Averages
2.75
High
3.00
Alliance Global
Buy
downgrade
2025-11-14
Reason
Alliance Global
Price Target
2025-11-14
downgrade
Buy
Reason
Alliance Global lowered the firm's price target on Tenon Medical to $2.50 from $2.75 and keeps a Buy rating on the shares. The firm's revised target reflects lower forecasts following the company's Q3 report.
Alliance Global Partners
Buy
downgrade
$3
2025-05-14
Reason
Alliance Global Partners
Price Target
$3
2025-05-14
downgrade
Buy
Reason
Alliance Global Partners lowered the firm's price target on Tenon Medical to $2.50 from $3 and keeps a Buy rating on the shares, citing lower forecasts after Tenon reported Q1 results that were within the firm's expectations, including a revenue shortfall offset by lower expenses.
Alliance Global Partners
Scott Henry
Strong Buy
Initiates
$3
2025-04-09
Reason
Alliance Global Partners
Scott Henry
Price Target
$3
2025-04-09
Initiates
Strong Buy
Reason
Alliance Global Partners initiated coverage of Tenon Medical with a Buy rating and $3 price target. The company is designing, developing, and selling a surgical implant system to treat severe lower back pain, the analyst tells investors in a research note. The firm expects strong revenue growth for Catamaran and believes it could drive the company into profitability. It believes the market for sacroiliac joint treatment is substantial.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Tenon Medical Inc (TNON.O) is -0.98, compared to its 5-year average forward P/E of -3.06. For a more detailed relative valuation and DCF analysis to assess Tenon Medical Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-3.06
Current PE
-0.98
Overvalued PE
12.84
Undervalued PE
-18.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
6.89
Current PS
0.00
Overvalued PS
40.98
Undervalued PS
-27.21
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

TNON News & Events

Events Timeline

(ET)
2025-12-04
08:40:00
Tenon Medical Completes First Clinical Procedures with SImmetry+ SI Joint Fusion System
select
2025-11-11 (ET)
2025-11-11
08:19:23
Tenon Medical sets PIPE financing price at $1.285 for 2.2 million shares
select
2025-10-21 (ET)
2025-10-21
08:45:34
Tenon Medical Receives 510(k) Approval for SImmerty+ SI Joint Fusion System
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
08-14NASDAQ.COM
Tenon Medical (TNON) Q2 2025 Earnings Transcript
  • Author's Perspective: The opinions shared in the article are solely those of the author and do not represent Nasdaq, Inc.
  • Data Limitations: The information is based on data available up to October 2023.
[object Object]
Preview
9.5
08-14NASDAQ.COM
Tenon Medical Revenue Falls 37 Percent

  • Financial Performance and Acquisition: Tenon Medical reported a 37.4% decline in revenue for Q2 2025, alongside a significant reduction in operating expenses. The recent acquisition of CyVantage is expected to enhance product offerings and facilitate revenue recovery.

  • Product Launches and Market Expansion: The company plans to launch the Catamaran SE implant this quarter and initiate alpha surgeries for Symmetry Plus by year-end, aiming to expand its market presence in sacropelvic fixation and drive sales growth through strategic integration and cross-selling opportunities.

[object Object]
Preview
9.5
08-06Benzinga
Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

  • Astera Labs Financial Performance: Astera Labs, Inc. shares surged 17.3% in pre-market trading after reporting a record $191.9 million in revenue for Q2, a 20% increase from the previous quarter and a 150% year-over-year rise, along with optimistic third-quarter guidance.

  • Market Movements: Several stocks experienced significant pre-market trading fluctuations, with BiomX Inc. gaining 34.2% following a stake report by Morgan Stanley, while LifeMD, Inc. saw a decline of 28.8% due to disappointing financial results and weak guidance.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Tenon Medical Inc (TNON) stock price today?

The current price of TNON is 1.13 USD — it has increased 0 % in the last trading day.

arrow icon

What is Tenon Medical Inc (TNON)'s business?

Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Its trademarks include Catamaran, PiSIF, CAT PiSIF, ETAD, CAT SIJ Fusion System, SImmetry, MAINSAIL, SImmetry+, Catamaran Transfixation Fusion Device, Catamaran Transfixation Fusion System, and others. The Catamaran SI Joint Fusion System offers a novel, less invasive Inferior-Posterior approach to the SI joint using a single, robust titanium implant.

arrow icon

What is the price predicton of TNON Stock?

Wall Street analysts forecast TNON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TNON is 2.75 USD with a low forecast of 2.50 USD and a high forecast of 3.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Tenon Medical Inc (TNON)'s revenue for the last quarter?

Tenon Medical Inc revenue for the last quarter amounts to 1.17M USD, increased 32.24 % YoY.

arrow icon

What is Tenon Medical Inc (TNON)'s earnings per share (EPS) for the last quarter?

Tenon Medical Inc. EPS for the last quarter amounts to -0.40 USD, decreased -88.98 % YoY.

arrow icon

What changes have occurred in the market's expectations for Tenon Medical Inc (TNON)'s fundamentals?

The market is revising Upward the revenue expectations for Tenon Medical, Inc. (TNON) for FY2025, with the revenue forecasts being adjusted by 1.45% over the past three months. During the same period, the stock price has changed by -4.24%.
arrow icon

How many employees does Tenon Medical Inc (TNON). have?

Tenon Medical Inc (TNON) has 27 emplpoyees as of December 05 2025.

arrow icon

What is Tenon Medical Inc (TNON) market cap?

Today TNON has the market capitalization of 12.23M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free